Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Phapros Tbk's Beginning Cash Position for the quarter that ended in Mar. 2026 was Rp120,976 Mil.
PT Phapros Tbk's quarterly Beginning Cash Position
increased
from Sep. 2025 (Rp51,488 Mil) to Dec. 2025 (Rp92,381 Mil) and
increased
from Dec. 2025 (Rp92,381 Mil) to Mar. 2026 (Rp120,976 Mil).
PT Phapros Tbk's annual Beginning Cash Position
declined
from Dec. 2023 (Rp147,684 Mil) to Dec. 2024 (Rp65,836 Mil) but then
increased
from Dec. 2024 (Rp65,836 Mil) to Dec. 2025 (Rp92,004 Mil).
PT Phapros Tbk Beginning Cash Position Related Terms
PT Phapros Tbk Beginning Cash Position Historical Data
* Premium members only.
The historical data trend for PT Phapros Tbk's Beginning Cash Position can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Beginning Cash Position of Rp120,976 Mil mean?
PT Phapros Tbk (ISX:PEHA) has a Beginning Cash Position of Rp120,976 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Phapros Tbk and its competitors.
Is PT Phapros Tbk's Beginning Cash Position too high?
PT Phapros Tbk's current Beginning Cash Position is Rp120,976 Mil. Overall, PT Phapros Tbk has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Phapros Tbk's Beginning Cash Position compare to ZTS and UTHR?
PT Phapros Tbk's Beginning Cash Position of Rp120,976 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on PT Phapros Tbk and its competitors. PT Phapros Tbk's current Beginning Cash Position is Rp120,976 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Phapros Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Phapros Tbk (ISX:PEHA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp381.90, compared to a current price of Rp300.00 — trading 21.4% below its estimated fair value. The current Beginning Cash Position is Rp120,976 Mil. PT Phapros Tbk's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For PT Phapros Tbk (ISX:PEHA), the current Beginning Cash Position is Rp120,976 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Phapros Tbk (ISX:PEHA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Phapros Tbk stock appears to be undervalued.
The current stock price of Rp300.00 is trading 21.4% below its estimated GF Value™ of Rp381.90.
GuruFocus considers PT Phapros Tbk to be Modestly Undervalued.
Key valuation signals for ISX:PEHA:
Beginning Cash Position: Rp120,976 Mil
GF Value™: Rp381.90 vs. price of Rp300.00 (21.4% below fair value)
No single metric tells the full story. See the ISX:PEHA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Phapros Tbk is a pharmaceutical company in Indonesia. The company is engaged in the industrial/manufacturing sector by producing and/or trading medicines, health instruments, chemical goods, and other similar goods in import, export, and other kinds of industry. The company operates through Over Counter (OTC), Ethical, Generic Drugs Bearing (OGB), and Toll Manufacturing segments. It derives maximum revenue from OGB segment.
73GF Score
Get the complete analysis for ISX:PEHA
Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PEHA has been successfully added to your 
